Magnetic Activated Cell Sorting in Artificial Insemination With Donor Sperm (MACSIAD)

September 5, 2018 updated by: IVI Sevilla

Application of Magnetic Activated Cell Sorting (MACS) of Spermatozoa in Artificial Insemination Cycles With Donor Sperm (AID)

The aim of this study is to analyse the efficacy of MACS technique for the selection of spermatozoa and its effects on implantation, pregnancy and miscarriage rate. This study will be performed by two IVI clinics (IVI Sevilla and IVI Madrid) with the purpose of finding new techniques that allow us to better select spermatozoa and improve the results of assisted reproduction techniques.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sevilla, Spain, 41011
        • IVI Sevilla

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women who undergo artificial insemination with donor sperm
  • Signing an informed consent form to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: MACS is applied to the sperm sample
Previous to the AID technique, the sperm sample undergoes capacitation through Percoll density gradient and MACS
MACS is a technique that allow us to tag and detect apoptotic spermatozoa. These apoptotic spermatozoa have phosphatidylserine in their membranes, so we add magnetic beads with Annexin V, which binds specifically to phosphatidylserine. The spermatozoa are then tagged and can be retained in a magnetic field, allowing us to collect just the non-apoptotic spermatozoa.
NO_INTERVENTION: MACS is not applied to the sperm sample
Previous to the AID technique, MACS only undergoes capacitation through Percoll density gradient, but not MACS technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnancy rate
Time Frame: Ultrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.
The number of pregnancies confirmed by ultrasound divided by the number of artificial insemination cycles. Pregnancy is confirmed by ultrasound examination.
Ultrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.
Implantation rate
Time Frame: The beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.
The number of positive results of beta human chorionic gonadotropin (hCG) test divided by the number of artificial insemination cycles. Implantation is confirmed through the analysis of beta hCG in blood.
The beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.
Live birth rate
Time Frame: Live births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysis
The number of live births divided by the number of artificial insemination cycles
Live births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysis

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sperm cell concentration
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Concentration of sperm cells in sperm sample before and after applying the MACS technique
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm cell motility
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Proportion of sperm cells with progressive motility (according to World Health Organisation 2010 criteria) before and after applying the MACS technique
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm cell morphology
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Proportion of sperm cells with normal morphology (according to World Health Organisation 2010 criteria) before and after applying the MACS technique
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm cells vitality
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Proportion of live sperm cells before and after applying the MACS technique
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm sample volume
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
The volume of sperm obtained after masturbation
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 7, 2017

Primary Completion (ACTUAL)

February 16, 2018

Study Completion (ACTUAL)

April 13, 2018

Study Registration Dates

First Submitted

April 24, 2018

First Submitted That Met QC Criteria

September 5, 2018

First Posted (ACTUAL)

September 6, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 6, 2018

Last Update Submitted That Met QC Criteria

September 5, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IVISEV-006-IAD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on MACS technique

Subscribe